Unfortunately the certified CME article (1) makes only passing reference to the fact that mere heat accumulation can result in body temperatures above 38 °C, and that not every fever is caused by pyrogenics. I especially missed any mention of thirst fever owing to exsiccosis and hypohidrotic forms of ectodermal dysplasia, which are important differential diagnoses in childhood fever of unclear origin and can lead to fatalities (2, 3).
Thirst fever develops when a body has less water available than would be needed to regulate the body temperature through perspiration. Due to their more sensitive fluid balance, this is particularly common in infants. By contrast, most children with hypohidrotic ectodermal dysplasia are not capable of releasing surplus body heat through perspiration as they do not have sweat glands (4). In such cases, infant mortality—depending on the climate zone and healthcare provision—is between 2% and 20% (3). Antipyretic drugs are ineffective in this setting, in contrast to physical measures to lower the body temperature.
In fever of unknown origin, what also needs to be identified is whether the affected person is actually physically capable of sweating. The medical history and physical examination serve this purpose. For the most common form of hypohidrotic ectodermal dysplasia, there is a causal treatment approach that requires a diagnosis as early on as possible, and which is currently being evaluated in clinical studies (www.clinicaltrials.gov NCT01775462 und NCT01992289).
Footnotes
Conflict of interest statement
Professor Schneider has received consultancy fees from Edimer Pharmaceuticals and Gerson Lehman Group.
He has received speaker honoraria and/or reimbursed for conference delegate fees, travel expenses, and hotel expenses from Wyeth and Edimer Pharmaceuticals.
He has obtained third party funding from Wyeth, Novartis, Pervormance, and Edimer Pharmaceuticals.
He co-owns a patent for the treatment of X-linked hypohidrotic ectodermal dysplasia.
References
- 1.Niehues T. The febrile child: diagnosis and treatment. Dtsch Arztebl Int. 2013;110(45):764–774. doi: 10.3238/arztebl.2013.0764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Clarke A, Phillips DI, Brown R, Harper PS. Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child. 1987;62:989–996. doi: 10.1136/adc.62.10.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Blüschke G, Nüsken KD, Schneider H. Prevalence and prevention of severe complications of hypohidrotic ectodermal dysplasia in infancy. Early Hum Dev. 2010;86:397–399. doi: 10.1016/j.earlhumdev.2010.04.008. [DOI] [PubMed] [Google Scholar]
- 4.Schneider H, Hammersen J, Preisler-Adams S, Huttner K, Rascher W, Bohring A. Sweating ability and genotype in individuals with X-linked hypohidrotic ectodermal dysplasia. J Med Genet. 2011;48:426–432. doi: 10.1136/jmg.2010.084012. [DOI] [PubMed] [Google Scholar]